Anil K. Sood, MD
Professor
The University of Texas MD Anderson Cancer Center
1155 Herman P. Pressler
Unit 1362
Houston,
TX
USA
77030
Papers:
48 - Featured Poster
Wound healing gone awry: role for platelets in tumor growth after antiangiogenic therapy
51 - Featured Poster
More is not always better: thrombocytosis contributes to impaired chemotherapy response in ovarian cancer
61 - Scientific Plenary
Molecular predictors of residual disease in patients with ovarian cancer
69 - Featured Poster
Launching personalized surgical therapy for advanced ovarian cancer
102 - Featured Poster
Not your mother's bisphosphonate: targeting angiogenesis in ovarian cancer
171 - Poster Session A
A dose a day keeps the cancer away: metronomic albumin-bound paclitaxel and topotecan has potent antitumor activity in ovarian cancer
207 - Poster Session A
Impact of lymphovascular space invasion (LVSI) on survival of stage I epithelial ovarian cancer
236 - Poster Session A
Hitting the right mark: nonoverlapping Notch and PI3K alterations in ovarian cancer
284 - Poster Session A
Selective activation of Notch3 in high-grade serous ovarian cancer
326 - Poster Session A
Taking it up a Notch: implications for outcomes in endometrial cancer
354 - Poster Session B
Out with the old and in with the neoadjuvant: changes and influences in ovarian cancer practice patterns among Society of Gynecologic Oncology (SGO) members
Moderator Introductions
Discussant